Lord, Abbett & Co’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-141,392
| Closed | -$4.6M | – | 953 |
|
|
2017
Q2 | $4.6M | Sell |
141,392
-41,231
| -23% | -$1.34M | 0.01% | 777 |
|
|
2017
Q1 | $5.75M | Sell |
182,623
-2,083
| -1% | -$65.6K | 0.02% | 728 |
|
|
2016
Q4 | $5.43M | Buy |
184,706
+2,144
| +1% | +$63K | 0.02% | 724 |
|
|
2016
Q3 | $5.28M | Buy |
182,562
+24,936
| +16% | +$721K | 0.02% | 722 |
|
|
2016
Q2 | $4.08M | Buy |
157,626
+7,566
| +5% | +$196K | 0.01% | 753 |
|
|
2016
Q1 | $3.72M | Buy |
150,060
+18,596
| +14% | +$461K | 0.01% | 758 |
|
|
2015
Q4 | $4.63M | Buy |
+131,464
| New | +$4.63M | 0.01% | 756 |
|
|
2014
Q1 | – | Sell |
-923,875
| Closed | -$27M | – | 1109 |
|
|
2013
Q4 | $27M | Buy |
923,875
+260,854
| +39% | +$7.64M | 0.06% | 452 |
|
|
2013
Q3 | $20.3M | Sell |
663,021
-12,547
| -2% | -$384K | 0.05% | 515 |
|
|
2013
Q2 | $21.4M | Buy |
+675,568
| New | +$21.4M | 0.05% | 494 |
|